DBV Technologies ADR’s recently made public that its Member of 10% owner group EPIC Bpifrance unloaded Company’s shares for reported $10.07 million on Dec 17 ’25. In the deal valued at $4.85 per share,2,076,990 shares were sold. As a result of this transaction, EPIC Bpifrance now holds 8,595,472 shares worth roughly $178.61 million.
Then, EPIC Bpifrance sold 1,292,103 shares, generating $5,413,912 in total proceeds. Upon selling the shares at $4.19, the Member of 10% owner group now owns 7,303,369 shares.
Before that, Mohideen Pharis sold 6,496 shares. DBV Technologies ADR shares valued at $18,708 were divested by the Chief Medical Officer at a price of $2.88 per share. As a result of the transaction, Mohideen Pharis now holds 103,153 shares, worth roughly $2.14 million.
Cantor Fitzgerald initiated its DBV Technologies ADR [DBVT] rating to an Overweight in a research note published on December 15, 2025; the price target was $42. A number of analysts have revised their coverage, including Guggenheim’s analysts, who began to cover the stock in early December with a ‘”a Buy”‘ rating. Societe Generale revised its rating on January 04, 2023. It rated DBVT as “a Buy” which previously was an “a Hold”.
Price Performance Review of DBVT
On Friday, DBV Technologies ADR [NASDAQ:DBVT] saw its stock jump 10.53% to $20.78. Over the last five days, the stock has gained 22.16%. DBV Technologies ADR shares have risen nearly 327.57% since the year began. Nevertheless, the stocks have risen 8.40% over the past one year.
How much short interest is there in DBV Technologies ADR?
A steep rise in short interest was recorded in DBV Technologies ADR stocks on 2025-12-31, growing by 0.86 million shares to a total of 0.89 million shares. Yahoo Finance data shows the prior-month short interest on 2025-11-28 was 32231.0 shares. There was a rise of 96.38%, which implies that there is a positive sentiment for the stock.
